Events Archives - Page 2 of 128

1 minute read

Events
News

Intellia Therapeutics Announced Single Dose Of Ntla-2002 Led To A 98% Mean Reduction In Monthly Hereditary Angioedema Attack Rate, With An Average Follow-up Of Over 20 Months Across All Patients

June 2, 10:38 AM

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced long-term data from the Phase 1 portion of the

NTLA

1 minute read

Events
News

Gilead And Arcus Announced Etrumadenant Plus Zimberelimab, FOLFOX, And Bevacizumab Reduce Death Risk By 63% And Disease Progression by 73% vs Regorafenib In Phase 1b/2 Trial For Third-Line Metastatic Colorectal Cancer

By Charles Gross

June 2, 10:36 AM

Gilead Sciences, Inc. (NASDAQ:GILD) and Arcus Biosciences, Inc. (NYSE:RCUS) today announced new data from Cohort B of ARC-9, a Phase 1b/2 study evaluating the safety and efficacy of etrumadenant, a dual A2a/b adenosine

GILD

1 minute read

Events
News

Puma Biotechnology Announced Presentation of Findings From Phase II Study Of Alisertib In Endocrine-Resistant Metastatic Breast Cancer ASCO 2024

By Charles Gross

June 2, 10:03 AM

Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, announced the presentation of biomarker findings from a Phase II randomized clinical trial of alisertib alone vs. alisertib + fulvestrant for the

PBYI

2 minute read

EXCLUSIVE: ‘Creating Secure AI for Everyone,’ Says Co-CEO Of Brand Engagement Network

By Abbey Higginbotham

May 31, 3:25 PM

AI Unleashed: Exploring the Possibilities introduced BEN's AI advancements and HIPAA compliance, emphasizing security, privacy, and market growth.

BNAI

1 minute read

Elevance Health Shares Moving Higher; Co Now Presenting At Bernstein’s 40th Annual Strategic Decisions Conference At 9:00 a.m ET

By Benzinga Newsdesk

May 31, 9:14 AM

Elevance Health (NYSE:ELV) announced today that senior management is scheduled to present at Bernstein's 40th Annual Strategic Decisions Conferencein New York City, on May 31 at 9:00 a.m. Eastern Daylight Time (EDT). All

ELV

3 minute read

EXCLUSIVE: Cybersecurity Critical For AI Growth — ‘The Five Players Get Bigger… And Hopefully Better,’ Says Stephanie Link

By Abbey Higginbotham

May 30, 12:39 PM

Stephanie Link shares her investment strategy focused on India's economic growth, semiconductor industry's potential, and importance of cybersecurity at Benzinga's AI Unleashed event.

NVDA

1 minute read

BridgeBio Pharma Announces Results Of Five New Analyses Of Clinical Endpoints From Phase 3 ATTRibute-CM Study of Acoramidis In ATTR-CM At ISA

By Benzinga Newsdesk

May 29, 4:03 PM

- Acoramidis treatment resulted in increased serum transthyretin (TTR) levels by Day 28 that were sustained and were correlated with a reduced risk of all-cause mortality (ACM), cardiovascular mortality (CVM), and

BBIO

3 minute read

Musk Is An ‘Innovator,’ But GM Must ‘Think Through’ Stances Based On Company Values: Mary Barra

By Hayden Buckfire

May 23, 3:55 PM

Mary Barra's focus on GM's transition to electric vehicles, with a commitment to design, affordability, and driving range, and partnerships for charging network and competition with Tesla and Chinese manufacturers.

BRK

2 minute read

Events
Tech

Google’s Gemini-Integrated Search Innovations: What You Need To Know

By Hayden Buckfire

May 21, 3:45 PM

Alphabet Inc (NASDAQ:GOOGL) unveiled new AI features at I/O Conference to stay ahead of competition from OpenAI. Users can now search with photos and videos.

GOOGL

3 minute read

Microsoft Introduces New AI-Powered Features At Build Conference: What You Need To Know

By Vaishali Prayag

May 21, 3:44 PM

Microsoft Corporation (NASDAQ: MSFT) kicked off its annual Build developer conference on Tuesday. The three-day event, which started with a keynote from CEO Satya Nadella, is focused on providing developers with in-depth sessions on the latest tools and features for Windows 11 and Microsoft 365. This year, a significant emphasis is on new AI innovations and enhancements.

MSFT